Pharvaris Director Monges Sells 11,969 Shares

The transaction combined a cashless option exercise and share sale, while leaving a reported option balance expiring in 2033.

Available on EDGAR 09/25/2026 - 01:36 PM EDT Accepted by SEC EDGAR 09/25/2026 - 01:35 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Pharvaris N.V. director Viviane Monges exercised options to acquire 11,969 common shares on September 23, 2026, at an exercise price of $8.05 per share, then sold 11,969 shares in a cashless exercise. The sale price was a weighted average of $33.0457 per share, with individual prices ranging from $33.00 to $33.0801. The reported option balance after the exercise was 9,031, with an expiration date of April 6, 2033.

Insider Trade Summary

Exercise and Sale: 11,969 shares ($299K approx. pre-tax spread)

Exercise and Sale 3 txns

Insider Monges Viviane

Role Director

Sold 11,969 shs ($396K)

Approx. gross sale proceeds $396K

Approx. exercise cost $96K

Approx. pre-tax spread $299K

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy) F2	11,969	$0.00	$0.00
Exercise	Common Stock	11,969	$8.05	$96K
Sale	Common Stock F1	11,969	$33.0457	$396K

Holdings After Transaction: Stock Option (Right to Buy) — 9,031 options (Direct); Common Stock — 5,500 shares (Direct)

Footnotes (2)

1. F1. The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $33.00 to $33.0801. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
2. F2. 25% of the option vested on April 6, 2024 with the remaining shares vesting in 1/48 monthly installments thereafter.

Key Figures

Options exercised: 11,969 underlying common shares Exercise price: $8.05 per share Shares sold: 11,969 shares +4 more

7 metrics

Options exercised 11,969 underlying common shares September 23, 2026

Exercise price $8.05 per share Options exercised September 23, 2026

Shares sold 11,969 shares September 23, 2026; cashless exercise

Weighted average sale price $33.0457 per share September 23, 2026

Sale price range $33.00 to $33.0801 per share Individual sale transactions on September 23, 2026

Reported option balance after exercise 9,031 options Reported following the September 23, 2026 transaction

Option expiration date April 6, 2033 Reported option position

Key Terms

cashless exercise, weighted average sale price, exercise price, vesting

4 terms

cashless exercise financial

"shares sold in connection with the exercise of stock options in a cashless exercise transaction"

A cashless exercise is a way for an option holder to convert stock options into actual shares without paying the purchase price in cash; instead they immediately give up a portion of the newly issued shares to cover the cost and any withholding taxes. Investors care because this process increases the number of shares available and can slightly dilute existing holdings, while also signaling how insiders or employees are realizing compensation without needing cash — similar to paying for a purchase by handing over part of what you just bought.

weighted average sale price financial

"represents a weighted average sale price"

exercise price financial

"conversion or exercise price of $8.05"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vesting financial

"remaining shares vesting in 1/48 monthly installments"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many PHVS shares did director Viviane Monges sell, and at what price?

Viviane Monges sold 11,969 shares on September 23, 2026, at a weighted average price of $33.0457 per share. The reported sale prices ranged from $33.00 to $33.0801, and the sale was connected with a cashless option exercise.

How many PHVS options did Viviane Monges have after exercising?

The reported option balance following the exercise was 9,031, with an expiration date of April 6, 2033.

How did Viviane Monges's PHVS stock options vest?

Twenty-five percent of the option vested on April 6, 2024, with the remaining shares vesting in 1/48 monthly installments thereafter.

Was Viviane Monges's PHVS sale made under a Rule 10b5-1 plan?

No Rule 10b5-1 plan is reported for the transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Monges Viviane

(Last) (First) (Middle)

1 CRANBERRY HILL SUITE 400

(Street)

LEXINGTON MASSACHUSETTS 02421

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Pharvaris N.V. [ PHVS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/23/2026		M		11,969	A	$8.05	17,469	D
Common Stock	09/23/2026		S		11,969	D	$33.0457(1)	5,500	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$8.05	09/23/2026		M			11,969	(2)	04/06/2033	Common Stock	11,969	$0	9,031	D

Explanation of Responses:

1. The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $33.00 to $33.0801. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

2. 25% of the option vested on April 6, 2024 with the remaining shares vesting in 1/48 monthly installments thereafter.

	/s/ Marnus Nel, Attorney-in-Fact for Viviane Monges	09/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)